BioCardia, Inc. Files 8-K Report
Ticker: BCDA · Form: 8-K · Filed: May 6, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
BioCardia filed an 8-K, standard disclosure, no major news yet.
AI Summary
On May 6, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard regulatory filing.
Why It Matters
This filing serves as a public record of BioCardia, Inc.'s regulatory disclosures, providing transparency to investors and stakeholders regarding company events and financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information indicating immediate significant risk or opportunity.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- May 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 320 Soquel Way (address) — Principal executive offices
- Sunnyvale, California (location) — City and State of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for BioCardia, Inc.?
The filing is a Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934, covering 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated May 6, 2025.
In which state is BioCardia, Inc. incorporated?
BioCardia, Inc. is incorporated in Delaware.
What is the principal executive office address for BioCardia, Inc.?
The address of the principal executive offices is 320 Soquel Way, Sunnyvale, California 94085.
Does this excerpt detail any specific financial results or material events?
No, the provided excerpt of the 8-K filing does not detail specific financial results or material events; it primarily outlines the form type and reporting dates.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding BioCardia, Inc. (BCDA).